Attached files

file filename
S-1/A - AMENDMENT NO. 4 TO FORM S-1 - REATA PHARMACEUTICALS INCd84883ds1a.htm
EX-24.2 - EX-24.2 - REATA PHARMACEUTICALS INCd84883dex242.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 8, 2016, in Amendment No. 4 to the Registration Statement (Form S-1 No. 333-208843) and related Prospectus of Reata Pharmaceuticals, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Dallas, Texas

May 5, 2016